Drug
Non Immunogenic Staphylokinase
Non Immunogenic Staphylokinase: highest development phase Phase 3, developed by Supergene, LLC. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Supergene, LLC
Trials
| Drug | Phase | Indication |
|---|---|---|
| non-immunogenic staphylokinase NCT07324837 | Phase 3 | Ischemic Stroke, Acute |
Latest
No recent events.
Follow Non Immunogenic Staphylokinase on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.